[Heart transplantation and assist devices]

Area of Science:

• Cardiology and Transplant Medicine
• Biomedical Engineering

Context:

• Chronic heart failure management remains challenging, with high mortality despite therapeutic advances.
• Heart transplantation is the optimal treatment for end-stage heart disease, but organ scarcity necessitates alternative solutions.
• Mechanical assist devices are increasingly used, transitioning from experimental to routine procedures.

Purpose:

• To investigate long-term complications and optimize immunosuppressive strategies following cardiac transplantation.
• To evaluate the efficacy of mechanical assist devices in managing end-stage heart failure.
• To improve patient quality of life in advanced heart disease treatment.

Summary:

• Current research in cardiac transplantation aims to prevent cardiac allograft vasculopathy and minimize adverse effects of immunosuppression.
• Mechanical assist device implantation faces challenges, particularly recurrent infections, limiting long-term utility.
• Ongoing studies are crucial for a comprehensive understanding and definitive judgment of assist device performance.

Impact:

• Advances in immunosuppression and device technology can enhance survival rates and quality of life for heart failure patients.
• Addressing long-term complications is vital for establishing durable and effective treatments for advanced heart disease.
• Improved outcomes for heart transplantation and mechanical assist devices will expand treatment options for a growing patient population.